Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
- 1 August 1978
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 75 (8), 3948-3952
- https://doi.org/10.1073/pnas.75.8.3948
Abstract
An intact alternative pathway of [human] complement [C] activation was assembled from 6 isolated proteins present at their respective physiological concentrations (C3 [component 3], 1200 .mu.g/ml; factor B, 200 .mu.g/ml; factor D, 2 .mu.g/ml; .beta.1H, 560 .mu.g/ml; C3b [b fragment of C3] inactivator, 34 .mu.g/ml; and native properdin, 20 .mu.g/ml). Initiation of the pathway required the presence of 5 of these proteins not including properdin. The initial C3 convertase of the system was a fluid-phase rather than a surface-bound enzyme. The ability of the pathway to discriminate between activator and nonactivator resides in the bound C3b molecule. When bound to the surface of an activator through its labile binding site, C3b interacts with surface structures of the activator through another site on the molecule. This interaction results in diminished .beta.1H binding to C3b and thereby allows the bound C3b molecule to escape control and participate in C3 convertase formation. Initiation of the alternative pathway is a 2-step process, the 1st being nonspecific and the 2nd being discriminatory.This publication has 20 references indexed in Scilit:
- Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cellsProceedings of the National Academy of Sciences, 1978
- Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathwayProceedings of the National Academy of Sciences, 1978
- Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteinsThe Journal of Experimental Medicine, 1977
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Activation of the alternative complement pathway due to resistance of zymosan-bound.Proceedings of the National Academy of Sciences, 1977
- Alternative Pathway of Complement: Nonenzymatic, Reversible Transition of Precursor to Active ProperdinThe Journal of Immunology, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Third component of human complement: purification from plasma and physicochemical characterizationBiochemistry, 1976
- Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.The Journal of Experimental Medicine, 1976
- Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.The Journal of Experimental Medicine, 1976